Urologix, Inc. (ULGX)

Market Cap	2.13K
Revenue (ttm)	12.00M -19.4%
Net Income	-4.67M
EPS	-0.22
Shares Out	21.28M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	290
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0251
Beta	-106.66
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Urologix

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethr...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1991
• Employees: 61
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULGX

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 14, 2026

Data Sources Report a data error